Abstract:Seven new compounds including four lanostane triterpenoids, lucidenic acids Q-S (1-3) and methyl ganoderate P (4), and three triterpene-farnesyl hydroquinone conjugates, ganolucinins A-C (5-7), one new natural product ganomycin J (8), and 73 known compounds (9-81) were isolated from fruiting bodies of Ganoderma lucidum. The structures of the compounds 1-8 were determined by spectroscopic methods. Bioactivities of compounds isolated were assayed against HMG-CoA reductase, aldose reductase, α-glucosidase, and PTP1B. Ganolucidic acid η (39), ganoderenic acid K (44), ganomycin J (8), and ganomycin B (61) showed strong inhibitory activity against HMG-CoA reductase with IC50 of 29.8, 16.5, 30.3 and 14.3μM, respectively. Lucidumol A (67) had relatively good effect against aldose reductase with IC50 of 19.1μM. Farnesyl hydroquinones ganomycin J (8), ganomycin B (61), ganomycin I (62), and triterpene-farnesyl hydroquinone conjugates ganoleuconin M (76) and ganoleuconin O (79) possessed good inhibitory activity against α-glucosidase with IC50 in the range of 7.8 to 21.5μM. This work provides chemical and biological evidence for the usage of extracts of G. lucidum as herbal medicine and food supplements for the control of hyperglycemic and hyperlipidemic symptoms.

Highly modified lanostane triterpenoids from natural fruiting bodies of Ganoderma cf. hochiminhense

Isolation of 3,4-Seco-27-norlanostane Triterpenoids from Cultivated Fruiting Bodies of Ganoderma Orbiforme

Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense.

Lanostane triterpenoids from the fruiting bodies of Ganoderma amboinense

New Lanostane-Type Triterpenoids from the Fruiting Body of Ganoderma Hainanense

Highly Oxygenated Lanostane-Type Triterpenoids and Their Bioactivity from the Fruiting Body of Ganoderma Gibbosum

New Lanostane-Type Triterpenoids from Ganoderma Applanatum.

Lanostane triterpenoids with cytotoxic activities from the fruiting bodies of Ganoderma hainanense.

Three New Lanostanoids From The Mushroom Ganoderma Tropicum

Cytotoxic lanostanoid triterpenes from Ganoderma lucidum.

Antidiabetic lanostane triterpenoids from the fruiting bodies of Ganoderma weberianum

Lanostane triterpenoids with anti-proliferative and anti-inflammatory activities from medicinal mushroom Ganoderma lingzhi

Anti-HIV-1 Protease Activity of Lanostane Triterpenes from the Vietnamese Mushroom Ganoderma Colossum

Lanostane triterpenoids with anti-proliferative and PTP1B/α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma calidophilum

New ganoderic acids, bioactive triterpenoid metabolites from the mushroom Ganoderma lucidum

New lanostane-type triterpenoids with proangiogenic activity from the fruiting body of Ganoderma applanatum

Lanostane-type Triterpenoids from the Fruiting Body of Ganoderma Calidophilum

Two New Lanostanoids from Ganoderma Resinaceum.

Triterpenes and meroterpenes from Ganoderma lucidum with inhibitory activity against HMGs reductase, aldose reductase and α-glucosidase

Lanostane Triterpenoids from the Fruiting Bodies of Fomes Officinalis and Their Anti-Inflammatory Activities

Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase